Shares of Express Scripts Holding Co. (NASDAQ:ESRX) have been given a consensus recommendation of “Hold” by the twenty-three ratings firms that are covering the company. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and nine have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $81.50.

ESRX has been the topic of a number of analyst reports. Zacks Investment Research raised Express Scripts Holding from a “hold” rating to a “buy” rating and set a $79.00 price target on the stock in a research note on Thursday, October 27th. Deutsche Bank AG raised Express Scripts Holding from a “sell” rating to a “hold” rating and lifted their price target for the stock from $69.00 to $70.00 in a research note on Thursday, November 3rd. They noted that the move was a valuation call. Credit Suisse Group AG reissued an “outperform” rating and issued a $85.00 price target on shares of Express Scripts Holding in a research note on Monday, October 3rd. Jefferies Group reissued a “buy” rating and issued a $88.00 price target on shares of Express Scripts Holding in a research note on Monday, August 29th. Finally, Sanford C. Bernstein reissued an “underperform” rating and issued a $68.00 price target on shares of Express Scripts Holding in a research note on Tuesday, September 6th.

In other news, Director Woodrow A. Myers, Jr. sold 12,036 shares of the business’s stock in a transaction that occurred on Wednesday, September 14th. The stock was sold at an average price of $70.40, for a total transaction of $847,334.40. Following the sale, the director now directly owns 14,918 shares in the company, valued at $1,050,227.20. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, VP Christopher A. Mcginnis sold 1,785 shares of the business’s stock in a transaction that occurred on Monday, September 12th. The shares were sold at an average price of $70.77, for a total value of $126,324.45. Following the sale, the vice president now owns 4,955 shares in the company, valued at $350,665.35. The disclosure for this sale can be found here. Insiders own 0.54% of the company’s stock.

Several hedge funds have recently added to or reduced their stakes in the stock. Oakworth Capital Inc. boosted its stake in shares of Express Scripts Holding by 0.6% in the third quarter. Oakworth Capital Inc. now owns 1,802 shares of the company’s stock worth $127,000 after buying an additional 10 shares during the period. Checchi Capital Advisers LLC boosted its stake in shares of Express Scripts Holding by 0.5% in the second quarter. Checchi Capital Advisers LLC now owns 6,561 shares of the company’s stock worth $497,000 after buying an additional 30 shares during the period. Bath Savings Trust Co boosted its stake in shares of Express Scripts Holding by 1.2% in the second quarter. Bath Savings Trust Co now owns 3,217 shares of the company’s stock worth $244,000 after buying an additional 38 shares during the period. Enterprise Financial Services Corp boosted its stake in shares of Express Scripts Holding by 0.7% in the third quarter. Enterprise Financial Services Corp now owns 6,032 shares of the company’s stock worth $426,000 after buying an additional 41 shares during the period. Finally, Dorsey & Whitney Trust CO LLC boosted its stake in shares of Express Scripts Holding by 0.5% in the third quarter. Dorsey & Whitney Trust CO LLC now owns 8,626 shares of the company’s stock worth $609,000 after buying an additional 42 shares during the period. Institutional investors and hedge funds own 90.13% of the company’s stock.

Shares of Express Scripts Holding (NASDAQ:ESRX) traded down 1.30% on Wednesday, hitting $76.14. 2,428,961 shares of the stock traded hands. Express Scripts Holding has a one year low of $64.46 and a one year high of $89.00. The company’s 50 day moving average is $70.38 and its 200 day moving average is $73.66. The stock has a market cap of $46.95 billion, a price-to-earnings ratio of 18.00 and a beta of 0.96.

Express Scripts Holding (NASDAQ:ESRX) last issued its quarterly earnings results on Tuesday, October 25th. The company reported $1.74 EPS for the quarter, hitting the consensus estimate of $1.74. Express Scripts Holding had a net margin of 2.70% and a return on equity of 24.99%. The firm had revenue of $25.41 billion for the quarter, compared to analysts’ expectations of $25.48 billion. During the same period in the previous year, the business earned $1.45 earnings per share. Express Scripts Holding’s revenue for the quarter was up .7% compared to the same quarter last year. On average, equities analysts forecast that Express Scripts Holding will post $6.39 EPS for the current year.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

5 Day Chart for NASDAQ:ESRX

Receive News & Stock Ratings for Express Scripts Holding Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Co. and related stocks with our FREE daily email newsletter.